View Larger Image Fibroblast Activation Protein (FAP) Inhibitors as Biomarkers in Oncology, Fibrotic Disease, and Cardiovascular Disease Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer Informa Connect: Radiopharmaceuticals and Imaging Digital Conference March 14, 2023 Download the Presentation sofie_c557hm2025-10-15T16:42:12+00:00March 14th, 2023|Presentations| Share This Story, Choose Your Platform! FacebookXLinkedInPinterest Related Posts Current State of FAP Ligands for Diagnostic Use in Oncology Gallery Current State of FAP Ligands for Diagnostic Use in Oncology June 14th, 2024 [68Ga]FAPI-46 Phase 2 clinical development updates Gallery [68Ga]FAPI-46 Phase 2 clinical development updates June 9th, 2024 Current State of FAP Targeting Radioligands Gallery Current State of FAP Targeting Radioligands May 30th, 2024 Advancements in Diagnostics Gallery Advancements in Diagnostics March 23rd, 2024 Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy Gallery Fibroblast Activation Protein (FAP) – a target for Imaging and Therapy July 25th, 2023
![[68Ga]FAPI-46 Phase 2 clinical development updates](https://sofie.com/wp-content/uploads/2024/06/FAPI_Presentation2-500x383.jpg)
